Kestra Medical Technologies (KMTS) Accounts Payables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Accounts Payables data on file, last reported at $24.0 million in Q1 2026.

• Quarterly Accounts Payables fell 6.37% year-over-year to $24.0 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $24.0 million (down 6.37% YoY) and the FY2025 annual result came in at $24.0 million, changed 0.29% from the prior year.
• Accounts Payables advanced to $24.0 million in Q1 2026 per KMTS's latest filing, from $20.2 million in the prior quarter.
• Across five years, Accounts Payables topped out at $25.7 million in Q1 2025 and bottomed at $18.6 million in Q3 2025.
• The 3-year median for Accounts Payables is $23.9 million (2024), against an average of $22.7 million.
• The widest annual swing landed in 2025, when Accounts Payables gained 0.29%; it then declined 6.37% in 2026.
• Tracing KMTS's Accounts Payables over 3 years: stood at $23.9 million in 2024, then declined by 15.42% to $20.2 million in 2025, then grew by 18.87% to $24.0 million in 2026.
• Per Business Quant, the three latest KMTS Accounts Payables figures stand at $24.0 million (Q1 2026), $20.2 million (Q4 2025), and $18.6 million (Q3 2025).

Peer Comparison